116 related articles for article (PubMed ID: 27831653)
21. Metformin and epithelial ovarian cancer therapeutics.
Patel S; Kumar L; Singh N
Cell Oncol (Dordr); 2015 Oct; 38(5):365-75. PubMed ID: 26266765
[TBL] [Abstract][Full Text] [Related]
22. NANOG regulates epithelial-mesenchymal transition and chemoresistance in ovarian cancer.
Qin S; Li Y; Cao X; Du J; Huang X
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27884977
[TBL] [Abstract][Full Text] [Related]
23. Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells.
Yan H; Tong J; Lin X; Han Q; Huang H
Mol Med Rep; 2015 Aug; 12(2):1783-8. PubMed ID: 25891642
[TBL] [Abstract][Full Text] [Related]
24. LncSOX4 serves an oncogenic role in the tumorigenesis of epithelial ovarian cancer by promoting cell proliferation and inhibiting apoptosis.
Liu Y; Wang Y; Yao D; Cui D
Mol Med Rep; 2018 Jun; 17(6):8282-8288. PubMed ID: 29693704
[TBL] [Abstract][Full Text] [Related]
25. Silencing of BAG3 promotes the sensitivity of ovarian cancer cells to cisplatin via inhibition of autophagy.
Qiu S; Sun L; Jin Y; An Q; Weng C; Zheng J
Oncol Rep; 2017 Jul; 38(1):309-316. PubMed ID: 28628188
[TBL] [Abstract][Full Text] [Related]
26. The association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancers.
Noel EE; Yeste-Velasco M; Mao X; Perry J; Kudahetti SC; Li NF; Sharp S; Chaplin T; Xue L; McIntyre A; Shan L; Powles T; Oliver RT; Young BD; Shipley J; Berney DM; Joel SP; Lu YJ
Am J Pathol; 2010 Jun; 176(6):2607-15. PubMed ID: 20395447
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous suppression of Src and signal transducer and activator of transcription 3 inhibits the growth of epithelial ovarian cancer cells.
Lee SW; Yoo J; Lee SH; Kim D; Kim YM; Kim YT
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):75-9. PubMed ID: 23427943
[TBL] [Abstract][Full Text] [Related]
28. Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1.
Zhang H; Zhang X; Ji S; Hao C; Mu Y; Sun J; Hao J
Carcinogenesis; 2014 Aug; 35(8):1863-71. PubMed ID: 24858206
[TBL] [Abstract][Full Text] [Related]
29. Nigericin Inhibits Epithelial Ovarian Cancer Metastasis by Suppressing the Cell Cycle and Epithelial-Mesenchymal Transition.
Wang W; Zhao Y; Yao S; Cui X; Pan W; Huang W; Gao J; Dong T; Zhang S
Biochemistry (Mosc); 2017 Aug; 82(8):933-941. PubMed ID: 28941461
[TBL] [Abstract][Full Text] [Related]
30. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.
Wang Y; Mao H; Hao Q; Wang Y; Yang Y; Shen L; Huang S; Liu P
Regul Pept; 2012 Oct; 178(1-3):36-42. PubMed ID: 22759793
[TBL] [Abstract][Full Text] [Related]
31. Over-expression of CHAF1A in Epithelial Ovarian Cancer can promote cell proliferation and inhibit cell apoptosis.
Xia D; Yang X; Liu W; Shen F; Pan J; Lin Y; Du N; Sun Y; Xi X
Biochem Biophys Res Commun; 2017 Apr; 486(1):191-197. PubMed ID: 28286267
[TBL] [Abstract][Full Text] [Related]
32. Expression of Cyclin D1 gene in ovarian cancer and effect of silencing its expression on ovarian cancer cells based on the Oncomine database.
Quan LL; Liu JY; Qu LX; La H; Wang HL; Chen XX; Wang N; Wei ZZ
Bioengineered; 2021 Dec; 12(2):9290-9300. PubMed ID: 34806539
[TBL] [Abstract][Full Text] [Related]
33. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
[TBL] [Abstract][Full Text] [Related]
34. Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.
Chen J; Bai M; Ning C; Xie B; Zhang J; Liao H; Xiong J; Tao X; Yan D; Xi X; Chen X; Yu Y; Bast RC; Zhang Z; Feng Y; Zheng W
Oncogene; 2016 May; 35(19):2506-17. PubMed ID: 26364616
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression.
Zhang X; Liu J; Zang D; Wu S; Liu A; Zhu J; Wu G; Li J; Jiang L
Oncotarget; 2015 Jun; 6(17):15180-93. PubMed ID: 25893382
[TBL] [Abstract][Full Text] [Related]
36. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
Li Y; Mi C
Ai Zheng; 2003 Jun; 22(6):586-91. PubMed ID: 12948406
[TBL] [Abstract][Full Text] [Related]
37. High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma.
Kim CJ; Lee JW; Choi JJ; Choi HY; Park YA; Jeon HK; Sung CO; Song SY; Lee YY; Choi CH; Kim TJ; Lee JH; Kim BG; Bae DS
Eur J Cancer; 2011 Apr; 47(6):918-25. PubMed ID: 21134740
[TBL] [Abstract][Full Text] [Related]
38. Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma.
Aguirre D; Boya P; Bellet D; Faivre S; Troalen F; Benard J; Saulnier P; Hopkins-Donaldson S; Zangemeister-Wittke U; Kroemer G; Raymond E
Apoptosis; 2004 Nov; 9(6):797-805. PubMed ID: 15505422
[TBL] [Abstract][Full Text] [Related]
39. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
